Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 26
2023
|
Harold Eugene Ford Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+50.0%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+5.0%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
811
+3.85%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+6.13%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+22.35%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,342
+3.29%
|
$238,876
$178.89 P/Share
|
Jun 26
2023
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+14.8%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Kathryn Benesh Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+50.0%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+19.17%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,342
+1.56%
|
$238,876
$178.89 P/Share
|
Jun 26
2023
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+2.89%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
811
+22.37%
|
$144,358
$178.89 P/Share
|
Jun 26
2023
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,342
+2.85%
|
$238,876
$178.89 P/Share
|
Jun 26
2023
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
811
+22.29%
|
$144,358
$178.89 P/Share
|
Mar 28
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
194
+0.08%
|
$36,084
$186.45 P/Share
|
Mar 27
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
297
+0.12%
|
$54,945
$185.32 P/Share
|
Mar 27
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
13
+0.58%
|
$2,405
$185.32 P/Share
|
Mar 16
2023
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-0.72%
|
$20,196
$187.21 P/Share
|
Mar 15
2023
|
Jonathan L Marcus Sr MD General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,636
+50.0%
|
$479,752
$182.67 P/Share
|
Mar 15
2023
|
Lynne Fitzpatrick President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-1.47%
|
$31,122
$182.67 P/Share
|
Mar 15
2023
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-2.87%
|
$31,122
$182.67 P/Share
|
Mar 15
2023
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-3.82%
|
$37,128
$182.67 P/Share
|
Feb 16
2023
|
Bryan T Durkin Director |
SELL
Bona fide gift
|
Direct |
1,367
-1.99%
|
-
|
Jan 18
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,243
+0.5%
|
$217,525
$175.98 P/Share
|
Jan 18
2023
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
54
+2.38%
|
$9,450
$175.98 P/Share
|
Dec 31
2022
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,531
-9.22%
|
$3,449,208
$168.16 P/Share
|
Dec 28
2022
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
289
+0.12%
|
$48,552
$168.11 P/Share
|
Dec 28
2022
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
12
+0.55%
|
$2,016
$168.11 P/Share
|
Dec 15
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.55%
|
$18,910
$155.22 P/Share
|
Dec 02
2022
|
Robert J Tierney Jr Director |
BUY
Open market or private purchase
|
Direct |
1,500
+11.44%
|
$264,000
$176.55 P/Share
|
Nov 04
2022
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
48,645
+8.85%
|
$8,269,650
$170.0 P/Share
|
Sep 27
2022
|
William R Shepard Director |
BUY
Small Acquisition
|
Direct |
11
+0.51%
|
$1,980
$180.93 P/Share
|
Sep 20
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
97
-1.79%
|
$18,333
$189.29 P/Share
|
Sep 19
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Open market or private sale
|
Direct |
360
-6.22%
|
$68,400
$190.77 P/Share
|
Sep 16
2022
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-1.55%
|
$17,954
$191.56 P/Share
|
Sep 16
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.94%
|
$57,109
$191.56 P/Share
|
Sep 16
2022
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
317
-2.61%
|
$60,547
$191.56 P/Share
|
Sep 16
2022
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
52
-0.23%
|
$9,932
$191.56 P/Share
|
Sep 16
2022
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
111
-0.73%
|
$21,201
$191.56 P/Share
|
Sep 16
2022
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-1.45%
|
$16,235
$191.56 P/Share
|
Sep 16
2022
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-0.79%
|
$53,862
$191.56 P/Share
|
Sep 16
2022
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-1.69%
|
$72,007
$191.56 P/Share
|
Sep 16
2022
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
317
-0.74%
|
$60,547
$191.56 P/Share
|
Sep 16
2022
|
Lynne Fitzpatrick President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-0.64%
|
$14,325
$191.56 P/Share
|
Sep 16
2022
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
387
-0.7%
|
$73,917
$191.56 P/Share
|
Sep 16
2022
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
352
-0.92%
|
$67,232
$191.56 P/Share
|
Sep 15
2022
|
Suzanne Sprague COO & Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
2,752
+31.26%
|
-
|
Sep 15
2022
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-5.77%
|
$38,380
$190.77 P/Share
|
Sep 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,128
+11.45%
|
-
|
Sep 15
2022
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-2.59%
|
$140,600
$190.77 P/Share
|